Ranolazine for enhancing insulin secretion

Details for Australian Patent Application No. 2008240202 (hide)

Owner CV Therapeutics, Inc.

Inventors Belardinelli, Luiz; Dhalla, Arvinder; Leung, Kwan; Zeng, Dewan; Shryock, John

Agent Freehills

Pub. Number AU-A-2008240202

PCT Pub. Number WO2008/128086

Priority 60/911,457 12.04.07 US; 61/026,223 05.02.08 US; 60/977,009 02.10.07 US

Filing date 11 April 2008

Wipo publication date 23 October 2008

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

8 October 2009 PCT application entered the National Phase

  PCT publication WO2008/128086 Priority application(s): WO2008/128086

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008240205-Use of substrates as pharmacological chaperones

2008240197-Determining a geolocation solution of an emitter on earth based on weighted least-squares estimation